{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:56:06Z","timestamp":1793451366270,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T00:00:00Z","timestamp":1616630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009001","name":"University of York","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT104726"],"award-info":[{"award-number":["WT104726"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT108518"],"award-info":[{"award-number":["WT108518"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["730964"],"award-info":[{"award-number":["730964"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["TNA1802-02"],"award-info":[{"award-number":["TNA1802-02"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["10719953.1"],"award-info":[{"award-number":["10719953.1"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["315101"],"award-info":[{"award-number":["315101"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ymthe.2021.03.020","type":"journal-article","created":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T03:59:34Z","timestamp":1616817574000},"page":"2366-2377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan"],"prefix":"10.1016","volume":"29","author":[{"given":"Brima M.","family":"Younis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eltahir A.G.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Furini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Wiggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada","family":"Keding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Carraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas E.A.","family":"Musa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mujahid A.A.","family":"Abdarahaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mandefield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni","family":"Aebischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhian","family":"Gabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Layton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles J.N.","family":"Lacey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8796-4755","authenticated-orcid":false,"given":"Paul M.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Musa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2021.03.020_bib1","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2021.03.020_bib2","series-title":"Leishmaniasis","year":"2019"},{"key":"10.1016\/j.ymthe.2021.03.020_bib3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/bmj.326.7385.377","article-title":"Leishmaniasis: new approaches to disease control","volume":"326","author":"Davies","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ymthe.2021.03.020_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1473-3099(03)00517-6","article-title":"Post-kala-azar dermal leishmaniasis","volume":"3","author":"Zijlstra","year":"2003","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ymthe.2021.03.020_bib5","first-page":"275253","article-title":"Post-Kala-Azar Dermal Leishmaniasis: A Paradigm of Paradoxical Immune Reconstitution Syndrome in Non-HIV\/AIDS Patients","volume":"2013","author":"Khalil","year":"2013","journal-title":"J.\u00a0Trop. Med."},{"key":"10.1016\/j.ymthe.2021.03.020_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pt.2013.12.004","article-title":"Post kala-azar dermal leishmaniasis: an unresolved mystery","volume":"30","author":"Mukhopadhyay","year":"2014","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ymthe.2021.03.020_bib7","first-page":"708391","article-title":"Treatment-based strategy for the management of post-kala-azar dermal leishmaniasis patients in the Sudan","volume":"2013","author":"Musa","year":"2013","journal-title":"J.\u00a0Trop. Med."},{"key":"10.1016\/j.ymthe.2021.03.020_bib8","doi-asserted-by":"crossref","first-page":"e0005877","DOI":"10.1371\/journal.pntd.0005877","article-title":"Post-kala-azar dermal leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme","volume":"11","author":"Zijlstra","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ymthe.2021.03.020_bib9","doi-asserted-by":"crossref","first-page":"e00048-18","DOI":"10.1128\/CMR.00048-18","article-title":"Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives","volume":"31","author":"Alves","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ymthe.2021.03.020_bib10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1021\/acsinfecdis.8b00298","article-title":"Drug Discovery for Kinetoplastid Diseases: Future Directions","volume":"5","author":"Rao","year":"2019","journal-title":"ACS Infect. Dis."},{"issue":"Suppl 2","key":"10.1016\/j.ymthe.2021.03.020_bib11","doi-asserted-by":"crossref","first-page":"B244","DOI":"10.1016\/j.vaccine.2012.11.080","article-title":"Case study for a vaccine against leishmaniasis","volume":"31","author":"Alvar","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2021.03.020_bib12","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1016\/j.vaccine.2015.12.071","article-title":"Status of vaccine research and development of vaccines for leishmaniasis","volume":"34","author":"Gillespie","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2021.03.020_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1586\/14760584.2016.1105135","article-title":"Leishmania vaccine development: exploiting the host-vector-parasite interface","volume":"15","author":"Reed","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ymthe.2021.03.020_bib14","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.1016\/j.vaccine.2009.05.084","article-title":"Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis: a meta-analysis","volume":"27","author":"Noazin","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2021.03.020_bib15","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.1016\/j.vaccine.2008.09.085","article-title":"First generation leishmaniasis vaccines: a review of field efficacy trials","volume":"26","author":"Noazin","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2021.03.020_bib16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.trstmh.2007.08.006","article-title":"Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment","volume":"102","author":"Musa","year":"2008","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ymthe.2021.03.020_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1365-4362.2002.01336.x","article-title":"Immunochemotherapy for cutaneous leishmaniasis: a controlled trial using killed Leishmania (Leishmania) amazonensis vaccine plus antimonial","volume":"41","author":"Machado-Pinto","year":"2002","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.ymthe.2021.03.020_bib18","first-page":"159","article-title":"Immunotherapy as a treatment of American cutaneous leishmaniasis: preliminary studies in Brazil","volume":"34","author":"Mayrink","year":"1992","journal-title":"Parassitologia"},{"key":"10.1016\/j.ymthe.2021.03.020_bib19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/14760584.2018.1459191","article-title":"Vaccine candidates against leishmania under current research","volume":"17","author":"Iborra","year":"2018","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ymthe.2021.03.020_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4103\/ijpvm.IJPVM_116_18","article-title":"Leishmania Vaccines Entered in Clinical Trials: A Review of Literature","volume":"10","author":"Moafi","year":"2019","journal-title":"Int. J. Prev. Med."},{"key":"10.1016\/j.ymthe.2021.03.020_bib21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00232-006-0040-3","article-title":"Cholesterol in negatively charged lipid bilayers modulates the effect of the antimicrobial protein granulysin","volume":"212","author":"Barman","year":"2006","journal-title":"J.\u00a0Membr. Biol."},{"key":"10.1016\/j.ymthe.2021.03.020_bib22","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1086\/513439","article-title":"HLA class I-restricted T\u00a0cell epitopes of the kinetoplastid membrane protein-11 presented by Leishmania donovani-infected human macrophages","volume":"195","author":"Basu","year":"2007","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ymthe.2021.03.020_bib23","doi-asserted-by":"crossref","first-page":"234ra56","DOI":"10.1126\/scitranslmed.3008222","article-title":"Modular multiantigen T\u00a0cell epitope-enriched DNA vaccine against human leishmaniasis","volume":"6","author":"Das","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2021.03.020_bib24","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/nm933","article-title":"Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses","volume":"9","author":"St\u00e4ger","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2021.03.020_bib25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fimmu.2012.00005","article-title":"CD8(+) T\u00a0cells in leishmania infections: friends or foes?","volume":"3","author":"St\u00e4ger","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2021.03.020_bib26","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/infdis\/jir850","article-title":"Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector","volume":"205","author":"O\u2019Hara","year":"2012","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ymthe.2021.03.020_bib27","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1016\/j.vaccine.2007.05.010","article-title":"Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasis","volume":"25","author":"Moreno","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2021.03.020_bib28","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1462-5822.2012.01756.x","article-title":"Trafficking and release of Leishmania metacyclic HASPB on macrophage invasion","volume":"14","author":"Maclean","year":"2012","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.ymthe.2021.03.020_bib29","doi-asserted-by":"crossref","first-page":"e2031","DOI":"10.1371\/journal.pntd.0002031","article-title":"Polymorphism in the HASPB repeat region of East African Leishmania donovani strains","volume":"7","author":"Zackay","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ymthe.2021.03.020_bib30","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/infdis\/jir842","article-title":"Therapeutic vaccination with recombinant adenovirus reduces splenic parasite burden in experimental visceral leishmaniasis","volume":"205","author":"Maroof","year":"2012","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ymthe.2021.03.020_bib31","doi-asserted-by":"crossref","first-page":"e0005527","DOI":"10.1371\/journal.pntd.0005527","article-title":"A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH","volume":"11","author":"Osman","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ymthe.2021.03.020_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1475-9292-6-7","article-title":"Consultation meeting on the development of therapeutic vaccines for post kala azar dermal leishmaniasis","volume":"6","author":"Ghalib","year":"2007","journal-title":"Kinetoplastid Biol. Dis."},{"key":"10.1016\/j.ymthe.2021.03.020_bib33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/14760584.2020.1712199","article-title":"HIV therapeutic vaccines aimed at intensifying combination antiretroviral therapy","volume":"19","author":"Moretti","year":"2020","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ymthe.2021.03.020_bib34","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fimmu.2020.00188","article-title":"The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease","volume":"11","author":"Garbuglia","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2021.03.020_bib35","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3389\/fimmu.2019.00467","article-title":"Therapeutic Cancer Vaccine and Combinations With Antiangiogenic Therapies and Immune Checkpoint Blockade","volume":"10","author":"Mougel","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2021.03.020_bib36","doi-asserted-by":"crossref","first-page":"E27","DOI":"10.3390\/vaccines4030027","article-title":"Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection","volume":"4","author":"Swadling","year":"2016","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ymthe.2021.03.020_bib37","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nature20583","article-title":"Ad26\/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys","volume":"540","author":"Borducchi","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.03.020_bib38","doi-asserted-by":"crossref","first-page":"e1000431","DOI":"10.1371\/journal.ppat.1000431","article-title":"B7-H1 blockade increases survival of dysfunctional CD8(+) T\u00a0cells and confers protection against Leishmania donovani infections","volume":"5","author":"Joshi","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ymthe.2021.03.020_bib39","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.mehy.2005.03.035","article-title":"The pathogenesis of post kala-azar dermal leishmaniasis from the field to the molecule: does ultraviolet light (UVB) radiation play a role?","volume":"66","author":"Ismail","year":"2006","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ymthe.2021.03.020_bib40","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1179\/000349802125002211","article-title":"The natural history of Sudanese post-kala-azar dermal leishmaniasis: clinical, immunological and prognostic features","volume":"96","author":"Musa","year":"2002","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.ymthe.2021.03.020_bib41","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1179\/136485905X514127","article-title":"Efficacy of liposomal amphotericin B (AmBisome) in the treatment of persistent post-kala-azar dermal leishmaniasis (PKDL)","volume":"99","author":"Musa","year":"2005","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.ymthe.2021.03.020_bib42","first-page":"16","article-title":"Cure of post kala-azar dermal leishmaniasis with paromomycin\/sodium stibogluconate combination: a proof of concept International","volume":"3","author":"Younis","year":"2015","journal-title":"J.\u00a0Res. Med. Sci."},{"key":"10.1016\/j.ymthe.2021.03.020_bib43","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.pt.2019.06.007","article-title":"Post-Kala-Azar Dermal Leishmaniasis as a Reservoir for Visceral Leishmaniasis Transmission","volume":"35","author":"Le Rutte","year":"2019","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ymthe.2021.03.020_bib44","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/cid\/ciy891","article-title":"Quantifying the Infectiousness of Post-Kala-Azar Dermal Leishmaniasis Toward Sand Flies","volume":"69","author":"Mondal","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ymthe.2021.03.020_bib45","doi-asserted-by":"crossref","first-page":"e0007249","DOI":"10.1371\/journal.pntd.0007249","article-title":"Active surveillance identified a neglected burden of macular cases of Post Kala-azar Dermal Leishmaniasis in West Bengal","volume":"13","author":"Sengupta","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ymthe.2021.03.020_bib46","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1542\/peds.2006-0461","article-title":"Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women","volume":"118","author":"Block","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymthe.2021.03.020_bib47","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1001\/jama.2013.1625","article-title":"Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial","volume":"309","author":"Dobson","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ymthe.2021.03.020_bib48","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.3389\/fimmu.2019.02037","article-title":"Cysteine Cathepsins in Tumor-Associated Immune Cells","volume":"10","author":"Jako\u0161","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2021.03.020_bib49","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1007\/s00436-019-06374-y","article-title":"Susceptibility to leishmaniasis is affected by host SLC11A1 gene polymorphisms: a systematic review and meta-analysis","volume":"118","author":"Braliou","year":"2019","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ymthe.2021.03.020_bib50","first-page":"17","article-title":"Acquisition of cell-mediated immunity to Leishmania. II. LSH gene regulation of accessory cell function","volume":"65","author":"Kaye","year":"1988","journal-title":"Immunology"},{"key":"10.1016\/j.ymthe.2021.03.020_bib51","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1186\/s13071-016-1721-0","article-title":"The immunology of post-kala-azar dermal leishmaniasis (PKDL)","volume":"9","author":"Zijlstra","year":"2016","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.ymthe.2021.03.020_bib52","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3389\/fcimb.2019.00228","article-title":"Biomarkers in Post-kala-azar Dermal Leishmaniasis","volume":"9","author":"Zijlstra","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"Suppl 1","key":"10.1016\/j.ymthe.2021.03.020_bib53","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0035-9203(01)90218-4","article-title":"Leishmaniasis in Sudan. Visceral leishmaniasis","volume":"95","author":"Zijlstra","year":"2001","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ymthe.2021.03.020_bib54","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymthe.2021.03.020_bib55","first-page":"e2420v1","article-title":"tmod: an R package for general and multivariate enrichment analysis","volume":"4","author":"Weiner","year":"2016","journal-title":"PeerJ Preprints"},{"key":"10.1016\/j.ymthe.2021.03.020_bib56","first-page":"2825","article-title":"Scikit-learn: Machine Learning in Python","volume":"12","author":"Pedregosa","year":"2011","journal-title":"Journal of Machine Learning."},{"issue":"W1","key":"10.1016\/j.ymthe.2021.03.020_bib57","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2021.03.020_bib58","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in Ingenuity Pathway Analysis","volume":"30","author":"Kr\u00e4mer","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2021.03.020_bib59","series-title":"Stata Statistical Software: Release 16","year":"2019"},{"key":"10.1016\/j.ymthe.2021.03.020_bib60","series-title":"R: A Language and Environment for Statistical Computing","year":"2011"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001621001490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001621001490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:01:35Z","timestamp":1761501695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001621001490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1525001621001490"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2021.03.020","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.08.26.20180901","asserted-by":"object"}]},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2021.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s).","name":"copyright","label":"Copyright"}]}}